Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iduron is a specialist biotechnology company focused on the production and supply of high-quality glycosaminoglycans (GAGs) and related enzymes for medical research. Based in the United Kingdom and born out of the University of Manchester, the company provides a comprehensive range of heparin-derived oligosaccharides, heparan sulfate, and chondroitin sulfate variants. Their products are essential tools for researchers investigating the roles of GAGs in cell signaling, cancer progression, and inflammatory responses. Iduron also offers specialized analytical services and custom synthesis of complex carbohydrate structures to support drug discovery and development in the glycobiology sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iduron.